Lithium Ion Batteries for Implanted Medical Devices

Information

  • Research Project
  • 6732758
  • ApplicationId
    6732758
  • Core Project Number
    R44HL070383
  • Full Project Number
    5R44HL070383-03
  • Serial Number
    70383
  • FOA Number
  • Sub Project Id
  • Project Start Date
    4/5/2003 - 21 years ago
  • Project End Date
    3/31/2006 - 18 years ago
  • Program Officer Name
    BALDWIN, TIM
  • Budget Start Date
    4/1/2004 - 20 years ago
  • Budget End Date
    3/31/2006 - 18 years ago
  • Fiscal Year
    2004
  • Support Year
    3
  • Suffix
  • Award Notice Date
    2/2/2004 - 20 years ago

Lithium Ion Batteries for Implanted Medical Devices

[unreadable] DESCRIPTION (provided by applicant): [unreadable] State-of-the-art rechargeable batteries are incapable of providing the high energy densities required in order to free the device-implanted patient from a tethered external power source. The ability to provide a left ventricular assisted device patient or totally artificial heart patient with significantly more time "off-tether" would greatly improve his or her quality of life. Therefore, the aim of our proposed research is to develop advanced electrolyte materials and formulations thereof that would safely enable the extraction of more energy from an implanted lithium-ion (Li-ion) rechargeable battery. In Phase I we formulated a new family of ionic liquid-based gel-polymer electrolytes with remarkable properties including non-flammability, enhanced oxidative stability, and resistance to thermal excursions under conditions of forced overcharge as determined by differential scanning calorimetry. Li-ion cells that incorporated the new electrolytes could be repeatedly cycled at physiological temperatures to high charge potentials resulting in a significant increase in energy density. In Phase II we propose to refine the gel-polymer electrolyte formulation, particularly in respect to Li-ion cell safety at high voltages. Under a Consortium Agreement with Wilson Greatbatch Technologies (WGT) (Clarence, NY), our advanced electrolytes will be incorporated into spiral wound AA cells. WGT will subject these cells to a variety of abuse conditions including forced overcharge at elevated temperatures. We anticipate that the successful completion of Phase II will lead to a broad spectrum of advanced Li-ion batteries that offer significantly higher energy densities than are achievable with conventional electrolytes. [unreadable] [unreadable]

IC Name
NATIONAL HEART, LUNG, AND BLOOD INSTITUTE
  • Activity
    R44
  • Administering IC
    HL
  • Application Type
    5
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
    389333
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    837
  • Ed Inst. Type
  • Funding ICs
    NHLBI:389333\
  • Funding Mechanism
  • Study Section
    ZRG1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    COVALENT ASSOCIATES, INC.
  • Organization Department
  • Organization DUNS
  • Organization City
    WOBURN
  • Organization State
    MA
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    01801
  • Organization District
    UNITED STATES